Longevity & Aging · Metabolic & Cardiometabolic
chronic hyperinsulinemia increases risk of breast/colon/pancreatic/endometrial cancer
In plain terms: Does chronically high insulin raise cancer risk?
Yes for endometrial and colorectal cancer the association is robust, weaker/age-restricted for postmenopausal breast, and mixed for pancreatic, so the association is real but varies by cancer type.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (17)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Hazelwood 2022 · BMC Med | observational | supports | high | Multivariable Mendelian randomization found genetically higher fasting insulin causally increases endometrial cancer risk and mediates part of the BMI effect. |
| Li 2025 · Cancer Cell Int | observational | contradicts | low | East Asian two-sample MR found T2D genetically associated with LOWER risk of most cancers including endometrial/colorectal/breast, a disconfirming signal likely reflecting collider bias in Asian T2D GWAS. |
| Xu 2016 · BMJ Open | meta-analysis | supports | high | Meta-analysis found fasting insulin, HOMA-IR and C-peptide each significantly associated with increased colorectal cancer risk. |
| Grote 2011 · Diabetologia | observational | mixed | moderate | EPIC found pancreatic cancer risk related to diabetes/glycemia but C-peptide associations were weak and complicated by reverse causation from the tumor. |
| Yang 2026 · Medicine | observational | supports | moderate | Two-sample MR found genetically higher IGF-1 causally associated with increased colorectal (OR 1.22) and esophageal cancer risk. |
| Karmali 2015 · Blood Rev | mechanism | supports | moderate | Review details dysregulated insulin/IGF-1 signaling activating PI3K/Akt/mTOR and RAS/MAPK mitogenic pathways linking metabolic syndrome to malignancy. |
| Gaudet 2013 · Cancer Causes Control | observational | supports | moderate | CPS-II nested case-control: high C-peptide associated with postmenopausal breast cancer (T3 vs T1 OR 1.63, 1.08-2.45), attenuated after BMI adjustment. |
| Autier 2013 · Cancer Causes Control | meta-analysis | mixed | moderate | Meta-analysis found insulin/C-peptide associated with breast cancer chiefly in postmenopausal women, weaker/inconsistent overall. |
| Jenab 2007 · Int J Cancer | observational | supports | high | EPIC nested case-control (1,078 cases): highest vs lowest C-peptide quintile OR 1.56 (1.16-2.09) for colorectal cancer, stronger for colon. |
| Verheus 2006 · Cancer Epidemiol Biomarkers Prev | observational | mixed | moderate | EPIC found no overall C-peptide-breast cancer association; elevated risk only in nonfasting women over 60 (OR 2.03), so hyperinsulinemia link is age/postmenopausal-restricted. |
| Cust 2007 · Int J Cancer | observational | supports | moderate | EPIC: top vs bottom C-peptide quartile RR 2.13 (1.33-3.41) for endometrial cancer, attenuated to 1.56 after BMI adjustment. |
| Yoon 2015 · Metabolism | meta-analysis | supports | moderate | Meta-analysis linked hyperinsulinemia/insulin resistance markers to increased risk of colorectal adenoma, the CRC precursor. |
| Wolpin 2013 · J Natl Cancer Inst | observational | supports | high | Pooled prospective cohorts: higher prediagnostic insulin and proinsulin associated with increased pancreatic cancer risk. |
| Dashti 2021 · Cancer Epidemiol Biomarkers Prev | observational | supports | high | EPIC causal mediation analysis identified C-peptide (hyperinsulinemia) as a mediator of the adiposity-endometrial cancer link in postmenopausal women. |
| Ghadirzadeh 2026 · Acta Diabetol | meta-analysis | supports | high | Updated meta-analysis (35 studies) found diabetes associated with endometrial cancer, pooled RR 1.64 (1.50-1.80), independent of adiposity. |
| Rinaldi 2010 · Int J Cancer | meta-analysis | supports | moderate | EPIC plus meta-analysis of 10 prospective studies found a modest positive association of serum IGF-I with colorectal cancer (RR 1.07 per SD). |
| Simpson 2017 · Target Oncol | mechanism | supports | moderate | Review documents insulin/IGF-1R and INSR-A signaling driving proliferative/anti-apoptotic (mitogenic) pathways, the mechanistic basis for hyperinsulinemia promoting cancer. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.